Collect PROM data, increase revenue
Demonstrate positive treatment outcomes to achieve greater reimbursements. Clinical researchers value insights gained from patient-reported outcome measures (PROMs) and OutcomeMD highlights your impact.
With PROMs, you can demonstrate treatment effectiveness, secure approvals, and maximize reimbursements in a value-based care environment.
And because real-world, patient-reported data is highly sought after by biopharma, OutcomeMD delivers a new revenue stream by providing access to PROM data collected in clinical practice using our Patient Experience Data Network™
Better outcomes. Better reimbursements. Better business.
Value-based care takes center stage
Reimbursement is increasingly less about the procedure – and much more about the result. OutcomeMD focuses on your impact in delivering good outcomes.
Healthcare is shifting from volume to value. The Centers for Medicare and Medicaid Services (CMS) and commercial payers are linking payment directly to patient outcomes. PROMs are the evidence that makes this shift work, and our data network is what makes it easy.
- PROMs demonstrate measurable patient improvement
- Value-based reimbursement ties rates and bonuses to outcomes
- Providers gain performance incentives for documented success
- Targeted interventions improve care quality and efficiency
New revenue source – valuable PROM data
Biopharmaceutical firms value patient-reported outcome data to inform clinical research and go-to-market strategies for treatments. OutcomeMD licenses this real-world, de-identified PROM data to biopharmaceutical researchers who have joined our Patient Experience Data Network™ – securely and compliant – and shares the financial upside with you.
When your patients report outcomes, everyone benefits.
- FDA and EMA recognize PROMs as valid measures of efficacy
- Data complements clinical trials and delivers insights that inform clinical research leading to treatments
- PROMs provide real-world data for meaningful treatment changes
- De-identified PROM data trains AI models for risk prediction and patient stratification
- You receive a share of the licensing fees from biopharma
PROMs open the door to higher reimbursements
Using the power of our Patient Experience Data Network™, OutcomeMD supports value-based models with the wide range of data insurers and regulators require.
The result: the potential for more revenue, less manual work, and better care delivered at scale.
- Automate follow-up monitoring for insightful patient data
- Unlock approvals for challenging reimbursements
- Document treatments and patient success to support higher reimbursements
- Gain performance bonuses, avoid penalties for insufficient outcomes
- Enhance clinical research with the patient data you collect
- Meet compliance standards with ease
Bottom-line benefits for everyone
Better outcomes drive stronger reimbursements, happier patients, and healthier practices.
With OutcomeMD, patient voices fuel better medicine – and better outcomes. And with the power of our Patient Experience Data Network™, these benefits can be shared among everyone committed to better patient care.
Take full advantage of PROMs with OutcomeMD’s automated system: improve care, strengthen financial performance, and unlock new revenue streams.
Ready to improve patient care?
FAQs
How does OutcomeMD help with reimbursements?
PROMs provide the evidence payers demand – proving treatment effectiveness, supporting risk adjustments, and securing payment for codes that might otherwise be denied.
Are PROMs critical for higher reimbursement rates?
Yes. Payers increasingly trust patient-reported data as the most honest measure of success. PROMs are becoming essential to maximizing reimbursement.
Does this apply to surgery and specialty care too?
Absolutely. PROMs provide the level of proof insurers require across specialties, supporting higher rates and approvals for follow-up visits and care.
Are firms really willing to pay for PROMs data?
Yes. Biopharma firms actively seek PROMs data to complement trials and strengthen regulatory filings. Both the FDA and EMA accept PROMs as validated endpoints.
Can PROMs unlock payments for previously denied codes?
Yes. Documented, patient-reported data makes a strong case for reimbursement in areas that were historically denied.